AzTrials
AzTrials

Wound InfectionNCT04453319

Efficacy of Negative Pressure Wound Closure Therapy by PICO System in Prevention of Complications of Femoral Artery Exposure

A study testing Femoral Wound Closure and dressing in people with Wound Infection and Wound Surgical, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluate negative pressure wound closure therapy by PICO system in Prevention of complications of femoral artery exposure. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Wound Infection, Wound Surgical
What is being tested?
Femoral Wound Closure and dressing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteEgypt
Study dates
31 Jan 2020to 30 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • All femoral artery exposure whatever the type of surgery

Who cannot join

  • who can't give consent (unconscious)
  • Those with mental or behavioral disorders

Trial locations and contacts

1 site in 1 country.

Mosaad A Soliman, P.h.D contact

01001535711 ext. 002

soliman_mosaad@hotmail.com

Egypt1 site, 1 recruiting
  • Mansoura

    Al Mansurah, Mansoura University, 35111

    Mansoura UH Hospitals, 0502202876 ext. 0200, muh@mans.edu.eg

    Mansoura UH Hospitals, 050 2202750 ext. 0200, muh@mans.edu.eg

    Recruiting

Other trials in Egypt

About this study

Evaluate negative pressure wound closure therapy by PICO system in Prevention of complications of femoral artery exposure.

Read the detailed description

INTRODUCTION:

Wound infection is a very common complication in patients who undergo femoral artery exposure. It can lead to prolonged hospital stays, increased healthcare expenditures, admission times, graft failure, and limb loss and is recognized as a significant cause of postoperative morbidity and mortality.

Negative pressure wound therapy (NPWT) has been developped as a method for reducing the risk of wound complications and is the wound dressing of choice in many vascular procedures during the arterial exposure.

The idea of NPWT is a therapeutic technique wherein subatmospheric pressure is applied to a wound using a sealed wound dressing that is connected to a vacuum pump, which can be continuously or intermittently applied.

The mechanism of NPWT, is that it facilitates wound healing by decreasing the bacterial burden; promoting granulation tissue formation, capillary blood flow, endothelial proliferation, and angiogenesis; and restoring the integrity of the capillary basement membrane.

The clinical efficacy of NPWT for closed incisions has been extensively studied in surgical disciplines such as orthopedics, cardiothoracic, and plastic surgery, and its use in promoting wound healing and improving patient outcomes has been validated. The use of vacuum-assisted closure dressings (PICO system) is currently no evidenced that supports the use PICO system of for lower limb femoral incisions. Therefore, we aimed to evaluate the outcomes of PICO system in preventing wound complication in patients with femoral artery exposure.

Aim of the work Evaluate negative pressure wound closure therapy by PICO system in Prevention of complications of femoral artery exposure.

Outcome

Primary outcomes:

Infection Hematoma seroma

Secondary outcomes:

Wound Dehiscence. Patients and methods Study location: The study will be conducted at the department of vascular surgery in Mansoura university hospitals Type of study: Randomized controlled Prospective study Study duration: 2 years: 2019-2021 Sample size: 250 patients n=(Z^2 p(1-p))/d^2 Where: Z= 1.96 at 95% confidence level, P= expected prevalence, d= precision (margin of error)

Study population: The study will be conducted in all patients suspected to femoral artery exposure whatever the type of surgery Inclusion criteria: all patients suspected to femoral artery exposure whatever the type of surgery Exclusion criteria who can't give consent (unconscious)? Those with mental or behavioral disorders will be excluded. Consent: Patients after signing informed consent that possible complication from the procedure ought to happen and what are the alternatives.

Data collection: The demographics, Symptoms and preoperative clinical data will be collected History Data: included patient's demographics, underlying medical conditions, any previous associated morbidity.

Examination: Arterial assessments. Laboratory: Blood picture, Blood sugar level, Kidney functions, Liver functions and Coagulation profile.

Imaging: Duplex US and CTA Method of Randomization: Block randomization: Two elements A for Application of the device, B for conventional dressing A A B B A B A B A B B A B B A A B A B A B A A B Technique After closure of Femoral wound the PICO system is applied for up to 5-7 days. PICO® is a disposable, single-use pump without a canister that generates an effective, non-adjustable, negative pressure of -80 mmHg and that can be used for up to 7 days.(-1113) It incorporates leak detection and low battery indicators and is connected to a 4-layer absorbent dressing that primarily removes wound exudates through evaporative loss. The mechanism of action has been postulated to occur because of the combined effects of a reduction in the frequency of dressing changes, a reduction in stress concentration in the tissue surrounding the incision, and an enhancement in the appositional strength of the incision line, thus reducing dead space and minimizing the risk of wound contamination.(14) PICO® has also been demonstrated to enhance lymphatic clearance and decrease the risk of hematomas or seromas(15) Follow up Every patient will be followed every week till first month, then every 3 months till 1 years.

Hemodynamic improvement was assessed by ankle brachial pressure index (ABI), performed before and after the procedure and every 3 months.

Evaluation made to determine wound complications (Infection, Hematoma, seroma and wound dehiscence)

Statistical analysis The data will be analyzed using Statistical Package for the Social Sciences. The numerical outcomes e.g. age is calculated as mean. Gender will be recorded as frequency and percentage. Chi Square test is applied to assess the association of various parameters. The results will be considered statistically significant if the p-value is found to be less than or equal to 0.05.

Being tested
Femoral Wound Closure and dressing
Medical subject headings
Wound Infection, Surgical Wound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Femoral Wound Closure and dressingProcedure or surgery

    Femoral Wound Closure and dressing

Study groups in NCT04453319
Study groupRoleWhat they receive
Application of the device (PICO)ExperimentalPICO® is a disposable, single-use pump without a canister that generates an effective, non-adjustable, negative pressure of -80 mmHg and that can be used for up to 7 days.(-1113) It incorporates leak detection and low battery indicators and is connected to a 4-layer absorbent dressing that primarily removes wound exudates through evaporative loss. The mechanism of action has been postulated to occur because of the combined effects of a reduction in the frequency of dressing changes, a reduction in stress concentration in the tissue surrounding the incision, and an enhancement in the appositional strength of the incision line, thus reducing dead space and minimizing the risk of wound contamination.(14) PICO® has also been demonstrated to enhance lymphatic clearance and decrease the risk of hematomas or seromas
Receives: Procedure: Femoral Wound Closure and dressing
Conventional Dressing of the femoral woundNo interventionConventional Dressing of the femoral wound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Infection

    Clinical( fever, collection) and Radiological

    Measured: 12 months

  2. Hematoma

    Blood collected under the suture line

    Measured: 12 months

  3. seroma

    Fluid collected under the suture line

    Measured: 12 months

Secondary outcomes (1)
  1. Wound Dehiscence

    a wound ruptures along a surgical incision

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2020
  2. Study start31 Jan 2020
  3. Primary completion30 Jan 2021 (estimated)
  4. Study completion30 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Comparative study
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04453319
Sponsor's protocol ID
RP.19.12.52.R1 - 2020/01/31
Status last verified
Jun 2020
First submitted
21 Jun 2020
Last updated
1 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Correia RM, Nakano LC, Vasconcelos V, Cristino MA, Flumignan RL. Prevention of infection in peripheral arterial reconstruction of the lower limb. Cochrane Database Syst Rev. 2025 Oct 29;10(10):CD015022. doi: 10.1002/14651858.CD015022.pub2.

    PubMed 41159585

Questions about this trial

What is this clinical trial studying?

A study testing Femoral Wound Closure and dressing in people with Wound Infection and Wound Surgical, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mosaad A Soliman, P.h.D (01001535711 ext. 002, soliman_mosaad@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Infection (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04453319, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in